SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending after reporting strong earnings and significantly raising its future revenue guidance, fueled by accelerating AI cloud growth and massive, pre-funded customer demand for its infrastructure. The community is intensely debating a potential short squeeze and sustained rally, with many anticipating significant upgrades, while some speculate about a profit-taking sell-off at market open.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is surging after reporting its first-ever quarterly net profit and robust delivery guidance, fueling community excitement that its multi-brand strategy and advanced in-house AI chip development are positioning it as more than just an EV maker, with many anticipating a significant short squeeze.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Round Rock, TX.

TSS Inc

Investors are keenly awaiting TSSI's unexpectedly early earnings report, driving high community expectations for a significant rebound, especially given its integral role in Dell's expanding AI infrastructure following previous challenging quarters.

goeasy Ltd. engages in the provision of non-prime leasing and lending services. The company was founded by Gordon J. Reykdal on December 14, 1990 and is headquartered in Mississauga, Canada.

Goeasy Ltd

Goeasy Ltd. is trending due to the immediate suspension of its dividend and withdrawal of financial outlook, coupled with revelations of mismanagement, particularly regarding surging loan losses in its auto and powersports divisions. The community is actively discussing management's credibility, especially after a prior short report, with debates between calls for selling amidst bankruptcy fears and some investors eyeing a deep value buying opportunity.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

The Metals Company (TMC) is drawing significant attention after its consolidated deep-seabed mining application was deemed in substantial compliance by NOAA, marking a key regulatory milestone for the expanded project. The community is buzzing with optimism, anticipating further de-risking and discussing the geopolitical importance of securing critical minerals amidst global supply chain concerns.

Polaryx Therapeutics, Inc. engages in the manufacturing of biotechnology products. Its pipeline of products includes PLX-100, PLX-200, and PLX-300. The company was founded by Hahn-Jun Lee on August 22, 2014 and is headquartered in Paramus, NJ.

Polaryx Therapeutics Inc.

Polaryx Therapeutics (PLYX), a recently direct-listed clinical-stage biotech, is experiencing extreme volatility and massive trading volume following news of its planned Phase 2 trial for lead candidate PLX-200 for rare diseases. The community is buzzing with short squeeze speculation driven by a low float and high cost to borrow, despite concerns about potential dilution after dramatic price swings.

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Novartis AG - ADR

Novartis AG

Novartis is a key topic amid a flurry of positive clinical developments and strategic M&A, highlighted by recent trial success for drugs like remibrutinib and vanrafia, and significant acquisitions including Avidity Biosciences. These advancements are boosting sales forecasts and positioning the company as a leader in next-generation therapies, drawing strong community interest.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending after regaining NASDAQ compliance and reporting strong preliminary financial estimates, reinforcing a turnaround narrative, with the community actively debating its significant undervaluation and potential for a short squeeze.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is intensely trending as the community eagerly awaits pivotal Phase 3 REGAL trial results for its GPS drug in AML, with bullish investors anticipating a groundbreaking, potentially curative outcome and a major acquisition, while skeptics raise concerns about trial design and the company's valuation.

iShares Trust - iShares Biotechnology ETF

iShares Biotechnology ETF

The iShares Biotechnology ETF is experiencing significant trending interest due to a surge in M&A activity, with big pharma acquiring companies at substantial premiums, fostering community discussions around a new bullish phase for the sector driven by both these buyouts and the accelerating impact of AI on drug discovery.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Freshpet (FRPT) Falls More Steeply Than Broader Market: What Investors Need to Know

Freshpet (FRPT) closed the most recent trading day at $81.79, moving 1.26% from the previous trading session.

Newell's Productivity Plan & Other Strategies to Bolster Growth

NWL pushes its 'One Newell' realignment and consumer-led innovation to boost efficiency, margins and brand performance across core categories.

Freshpet, Inc. $FRPT Shares Sold by Neuberger Berman Group LLC

Neuberger Berman Group LLC trimmed its position in Freshpet, Inc. (NASDAQ:FRPT - Free Report) by 21.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange...

GW&K Investment Management LLC Sells 16,733 Shares of Freshpet, Inc. $FRPT

GW&K Investment Management LLC reduced its stake in Freshpet, Inc. (NASDAQ:FRPT - Free Report) by 6.7% during the 3rd quarter, according to the company in its most recent disclosure with the...

Is Clorox's International Expansion Key to Its Long-Term Success?

CLX's international push gains traction: segment sales rose 7% to $294M and EBIT jumped 48%, highlighting emerging markets as a key growth driver.

Royce & Associates LP Buys 19,502 Shares of Freshpet, Inc. $FRPT

Royce & Associates LP increased its stake in Freshpet, Inc. (NASDAQ:FRPT - Free Report) by 61.4% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The...

Brown-Forman's Q3 Earnings Beat Mark, Organic Sales Rise 1% Y/Y

BF.B beats Q3 estimates with 2% sales growth and higher margins, but weak U.S. demand and macro pressures keep the outlook cautious for fiscal 2026.


 Monster Beverage's Stock Falls 9% Post Q4 Earnings: What to Know?

MNST slips 9% after Q4 despite strong sales and earnings as tariffs, higher aluminum costs and rising expenses pressure margins amid a complex tariff backdrop.

Deepwater Asset Management LLC Grows Position in Freshpet, Inc. $FRPT

Deepwater Asset Management LLC grew its holdings in Freshpet, Inc. (NASDAQ:FRPT - Free Report) by 14.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The...

Freshpet, Inc. $FRPT Shares Sold by Champlain Investment Partners LLC

Champlain Investment Partners LLC trimmed its holdings in Freshpet, Inc. (NASDAQ:FRPT - Free Report) by 3.1% in the third quarter, according to its most recent disclosure with the Securities...

Freshpet, Inc. engages in the manufacturing, marketing, and distribution of pet food and pet treats for dogs and cats. Its products are blends of fresh meats, vegetables, and fruits farmed locally and made at Freshpet kitchens. Its products include Deli Fresh Grain Free Chicken Recipe for Dogs, Joy Turkey and Apple Bites Treats, Nature's Fresh Grain Free Chicken Recipe for Cats, and Vital Grain Free Chicken and Ocean Whitefish Recipe for Cats. The company was founded by Scott Morris and Cathal Walsh in November 2004 and is headquartered in Bedminster, NJ.

Current Price	$81.79
Prev Close	$82.83
Open	$82.67
Dividend Yield	0.00%
50-Day Moving Average	$70.64
Beta	1.02
Avg. Volume	1.44M
PE Ratio	32.27

52-Week High	$91.26
52-Week Low	$46.76
Market Capitalization	$4.06B
EPS (Annual)	$2.64
Price to Book	3.36
Revenue Per Employee	$855,601.71

FRPT
Freshpet Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FRPT News

FRPTFreshpet Inc